COVID-19
-
May 10, 2022
Report lays out solution for pandemic patient privacy
Health information privacy experts at Vanderbilt University Medical Center, the University of Texas at Dallas and IBM have collaborated on a public case reporting framework keyed to the dynamics of pandemics. -
May 10, 2022
Resistance to COVID-19 drug detected in lab study
Vanderbilt research shows that the virus that causes COVID-19 can develop partial resistance to the antiviral drug remdesivir during infection of cultured cells in the laboratory by more than one mechanism. -
May 5, 2022
COVID-associated bleeding risk
While case reports have noted acquired hemophilia after COVID-19 infection or vaccination, a new study finds no increased risk. -
April 25, 2022
VUMC offers second booster to eligible individuals
-
April 13, 2022
Additional COVID vaccine helps protect transplant patients
Additional booster doses of vaccine against COVID-19 are particularly important for those who are immunosuppressed, namely those who have had solid organ transplants, a new study shows. -
April 13, 2022
Volunteering for vaccine research a family affair
-
April 7, 2022
Study explores parents’ reluctance to flu, COVID vaccines for children
Vanderbilt research found parents who are reluctant to vaccinate their children against the flu are more than five times as likely to decline the COVID-19 vaccine for their children.